Albumin Corona Overturns Long‐Acting Behaviors of Myristic Acid‐Conjugated Quetiapine Nanosuspension
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Hy Dinh Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea. Hauptthemen laut MEDLINE: Myristic Acid, Nanoparticles, Quetiapine Fumarate, Protein Corona. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, Commercializations Promotion Agency for R and D Outcomes.
Abstract (Originalsprache)
This work aimed to investigate the interaction of a self‐assembled myristic acid‐conjugated quetiapine nanosuspension (QMN) with human serum albumin and its overturning effect on QMN's long‐acting performance. Albumin corona formation modified the physicochemical properties and pharmacokinetic profile of QMN by overturning its pH‐responsiveness and nano‐aggregation behavior. The adsorption of albumin on QMN is initially triggered by electrostatic forces and later by hydrophobic‐hydrophobic interactions with the conformational change of the albumin structure. While QMN is highly susceptible to ionic strength, pH, and albumin concentration in solution, albumin‐precoated QMN (A‐QMN) stabilized particle size and reversed the surface charge from ≈+60 to −16 mV, annulling the pH‐responsive nanoaggregation behaviors under physiological pH conditions. Consequently, A‐QMNs exhibited much faster in vitro release and more rapid in vivo absorption, resulting in a huge initial burst release and shorter duration within one week in plasma concentration‐time profiles compared to the extended five‐week duration of QMN following intramuscular injection in beagle dogs. These findings indicated the important role of serum proteins in the release kinetics and pharmacokinetics of the nanoparticles. The manipulation of protein corona can be utilized to control the physicochemical properties, biological states, and pharmacokinetics of intended long‐acting nanosuspensions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.
- Institute of Pharmaceutical Science and Technology, Ajou University, Suwon, 16499, Republic of Korea.
ORCID-Profile: Beom-Jin Lee
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT
- Commercializations Promotion Agency for R and D Outcomes
- Ministry of Science and ICT, South Korea
Zitieren
APA
Nguyen, H. D., Ngo, H. V., & Lee, B. J. (2025). Albumin Corona Overturns Long‐Acting Behaviors of Myristic Acid‐Conjugated Quetiapine Nanosuspension. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500851
Vancouver
Nguyen HD, Ngo HV, Lee BJ. Albumin Corona Overturns Long‐Acting Behaviors of Myristic Acid‐Conjugated Quetiapine Nanosuspension. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500851
BibTeX
@article{Nguyen2025,
author = {Nguyen, Hy Dinh and Ngo, Hai Van and Lee, Beom-Jin},
title = {Albumin Corona Overturns Long‐Acting Behaviors of Myristic Acid‐Conjugated Quetiapine Nanosuspension},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500851}
}
EUVIMED